Burt, M.G., Roberts, G.W., Aguilar-Loza, N.R., Frith, P.A., & Stranks, S.N., 2011. Continuous Monitoring Of Circadian Glycemic Patterns In Patients Receiving Prednisolone For COPD. Journal of Clinical Endocrinology and Metabolism, 96(6).

Currow, D.C., McDonald, C.F., Oaten, S., Kenny, B., Allcroft, P.D., Frith, P.A., Briffa, M., Johnson, M.J., & Abernethy, A.P., 2011. Once-daily opioids for chronic dyspnoea: a dose increment and pharmacovigilance study. Journal of Pain and Symptom Management, 42(3), 388-399.

Frith, P.A., Crockett, A.J., Beilby, J.J., Marshall, D., Attewell, R., Ratnanesan, A., & Gavagna, G., 2011. Simplified COPD screening: validation of the PiKo-6® in primary care. Primary Care Respiratory Journal, 20(2), 190-198.

Sladek, R., Jones, T., Phillips, P.A., Luszcz, M.A., Rowett, D.S., Eckermann, S.D., Woodman, R.J., & Frith, P.A., 2011. Health, economic, psychological and social impact of educating carers of patients with advanced pulmonary disease (protocol). Contemporary Clinical Trials, 32(5), 717-723.

Abernethy, A.P., McDonald, C.F., Frith, P.A., Clark, K., Herndon II, J.E., Marcello, J.E., Young, I., Bull, J., Wilcock, A., Booth, S., et al., 2010. Effect of palliative oxygen versus room air in relief of breathlessness in patients with refractory dyspnoea: a double-blind, randomised controlled trial. Lancet, 376, 784-793.

Williams, M., Cafarella, P.A., Olds, T., Petkov, J., & Frith, P.A., 2010. Affective Descriptors of the Sensation of Breathlessness Are More Highly Associated With Severity of Impairment Than Physical Descriptors in People With COPD. Chest, 138(2), 315-322.

Battersby, M.W., Harris, M., Reed, R.L., Harvey, P., Woodman, R.J., & Frith, P.A., 2010. A randomised trial of the Flinders Program to improve patient self-management competencies in a range of chronic conditions: study rationale and protocol. Australasian Medical Journal, 1(3), 198-204.

Hunt, T., Williams, M.T., Frith, P.A., & Schembri, D., 2010. Heliox, dyspnoea and exercise in COPD. European Respiratory Review, 19(115), 30-38.

Harris, M., Smith, B.J., Veale, A., Esterman, A.J., Frith, P.A., & Selim, P., 2009. Providing reviews of evidence to COPD patients: controlled prospective 12-month trial. Chronic Respiratory Disease, 6(3), 165-173.

Williams, M., Cafarella, P.A., Olds, T., Petkov, J., & Frith, P.A., 2008. The language of breathlessness differentiates between patients with COPD and age-matched adults. Chest, 134(3), 489-496.

Burt, M.G., Roberts, G.W., Aguilar-Loza, N.R., Frith, P.A., & Stranks, S.N., 2011. Continuous Monitoring Of Circadian Glycemic Patterns In Patients Receiving Prednisolone For COPD. Journal of Clinical Endocrinology and Metabolism, 96(6).

Currow, D.C., McDonald, C.F., Oaten, S., Kenny, B., Allcroft, P.D., Frith, P.A., Briffa, M., Johnson, M.J., & Abernethy, A.P., 2011. Once-daily opioids for chronic dyspnoea: a dose increment and pharmacovigilance study. Journal of Pain and Symptom Management, 42(3), 388-399.

Frith, P.A., Crockett, A.J., Beilby, J.J., Marshall, D., Attewell, R., Ratnanesan, A., & Gavagna, G., 2011. Simplified COPD screening: validation of the PiKo-6® in primary care. Primary Care Respiratory Journal, 20(2), 190-198.

Sladek, R., Jones, T., Phillips, P.A., Luszcz, M.A., Rowett, D.S., Eckermann, S.D., Woodman, R.J., & Frith, P.A., 2011. Health, economic, psychological and social impact of educating carers of patients with advanced pulmonary disease (protocol). Contemporary Clinical Trials, 32(5), 717-723.

Abernethy, A.P., McDonald, C.F., Frith, P.A., Clark, K., Herndon II, J.E., Marcello, J.E., Young, I., Bull, J., Wilcock, A., Booth, S., et al., 2010. Effect of palliative oxygen versus room air in relief of breathlessness in patients with refractory dyspnoea: a double-blind, randomised controlled trial. Lancet, 376, 784-793.

Battersby, M.W., Harris, M., Reed, R.L., Harvey, P., Woodman, R.J., & Frith, P.A., 2010. A randomised trial of the Flinders Program to improve patient self-management competencies in a range of chronic conditions: study rationale and protocol. Australasian Medical Journal, 1(3), 198-204.

Hunt, T., Williams, M.T., Frith, P.A., & Schembri, D., 2010. Heliox, dyspnoea and exercise in COPD. European Respiratory Review, 19(115), 30-38.

Williams, M., Cafarella, P.A., Olds, T., Petkov, J., & Frith, P.A., 2010. Affective Descriptors of the Sensation of Breathlessness Are More Highly Associated With Severity of Impairment Than Physical Descriptors in People With COPD. Chest, 138(2), 315-322.

Harris, M., Smith, B.J., Veale, A., Esterman, A.J., Frith, P.A., & Selim, P., 2009. Providing reviews of evidence to COPD patients: controlled prospective 12-month trial. Chronic Respiratory Disease, 6(3), 165-173.

Williams, M., Cafarella, P.A., Olds, T., Petkov, J., & Frith, P.A., 2008. The language of breathlessness differentiates between patients with COPD and age-matched adults. Chest, 134(3), 489-496.

Humphreys, K., Cross, G., Frith, P.A., & Cafarella, P.A., 2008. Nutritional status and dietary intake of outpatients with chronic obstructive pulmonary disease. Nutrition and Dietetics, 65(2), 168-174.

Currow, D.C., Plummer, J.L., Frith, P.A., & Abernethy, A.P., 2007. Can We Predict Which Patients with Refractory Dyspnea Will Respond to Opioids?. Journal of Palliative Medicine, 10(5), 1031-1036.

Battersby, M.W., Harvey, P., Mills, D., Kalucy, E.C., Pols, R.G., Frith, P.A., McDonald, P.J., Esterman, A.J., Tsourtos, G., Donato, R., et al., 2007. SA HealthPlus: a controlled trial of a statewide application of a generic model of chronic illness care. Milbank Quarterly, 85(1), 37-67.

Wilson, D.H., Tucker, G., Frith, P.A., Appleton, S., Ruffin, R.E., & Adams, R.J., 2007. Trends in hospital admissions and mortality from asthma and chronic obstructive pulmonary disease in Australia, 1993-2003. MJA Medical Journal of Australia, 186(8), 408-411.

Harris, M., Smith, B.J., Veale, A., Esterman, A.J., Frith, P.A., & Selim, P., 2006. Providing patients with reviews of evidence about COPD treatments: a controlled trial of outcomes. Chronic Respiratory Disease, 3(3), 133-140.

Smith, B.J., Dalziel, K., Mcelroy, H.J., Ruffin, R.E., Frith, P.A., Mccaul, K.A., & Cheok, F., 2005. Barriers to success for an evidence-based guideline for chronic obstructive pulmonary disease. Chronic Respiratory Disease, 2(3), 121-131.

Eckert, D.J., Catcheside, P.G., Smith, J.H., Frith, P.A., & McEvoy, R.D., 2004. Hypoxia suppresses symptom perception in asthma. American Journal of Respiratory and Critical Care Medicine, 169(11), 1224-1230.

Smith, Cheok, F., Heard, A.R., Esterman, A.J., Southcott, M., Antic, R., Frith, P.A., Hender, K., & Ruffin, R.E., 2004. Impact on readmission rates and mortality of a chronic obstructive pulmonary disease inpatient management guideline. Chronic Respiratory Disease, 1(1), 17-28.

Abernethy, A.P., Currow, D.C., Frith, P.A., Fazekas, B.S., McHugh, A., & Bui, C., 2003. Randomised, double blind, placebo controlled crossover trial of sustained release morphine for the management of refractory dyspnoea. British Medical Journal, 327(7414), 523-528.

McKenzie, D.K., Frith, P.A., Burdon, J.G., & Town, G.I., 2003. The COPDX Plan: Australian and New Zealand Guidelines for the management of Chronic Obstructive Pulmonary Disease 2003. MJA Medical Journal of Australia, 178(Suppl.), S1-S39.

Smith, B.J., Hender, K., Frith, P.A., Crockett, A.J., Cheok, F., & Spedding, S.J., 2003. Systematic assessment of clinical practice guidelines for the management of chronic obstructive pulmonary disease. Respiratory Medicine, 97(1), 37-45.

Heard, A., Kalucy, E.C., Richardson, D., Battersby, M.W., Frith, P.A., & Mcgowan, C., 2002. An evaluation of the care planning process in coordinated care trials: what difference do care plans make to service provision?. Australian Journal of Primary Health, 8(1), 52-56.

Smith, B.J., Mcelroy, H.J., Ruffin, R.E., Frith, P.A., Heard, A.R., Battersby, M.W., Esterman, A.J., Del Fante, P., & McDonald, P.J., 2002. The effectiveness of coordinated care for people with chronic respiratory disease. Medical Journal of Australia, 177(9), 481-485.

Warren, J., Noone, J.T., Smith, B.J., Ruffin, R.E., Van Der Zwaag, B.J., Beliakov, G.V., Frankel, H.K., & Frith, P.A., 2001. Automated attention flags in chronic disease care planning. Medical Journal of Australia, 175, 308-312.

Abramson, M.J., Crockett, A.J., Frith, P.A., & McDonald, C.F., 2006. COPDX: an update of guidelines for the management of chronic obstructive pulmonary disease with a review of recent evidence. MJA Medical Journal of Australia, 184(7), 342-345.

Frith, P.A., 2005. Impact of smoking, diabetes and hypertension on survival in the elderly: the Dubbo study (letter to the editor). Medical Journal of Australia, 182(9), 495-495.

Abernethy, A.P., Currow, D.C., Frith, P.A., & Fazekas, B.S., 2005. Prescribing palliative oxygen: a clinician survey of expected benefit and patterns of use. Palliative Medicine, 19(2), 168-170.

Currow, D.C., Abernethy, A.P., & Frith, P.A., 2003. Morphine for the management of refractory dyspnoea: opiates should be used with caution. British Medical Journal (Clinical Research Edition), 327(7426), 1288-1289.

Frith, P.A., Pal, S., & Pierce, R.J., 2001. Management of chronic obstructive pulmonary disease in the twenty first century. Internal Medicine Journal, 31(6), 508-511.

Frith, P.A., 2001. Managing COPD: What the GP needs to know. Medicine Today, 2(5), 20-24.

Antic, N.A. & Frith, P.A., 2001. Diagnosis sand management of asthma in the elderly. Medicine Today, 2(8), 20-27.

Paul, B., Magnoni, A., De Pasquale, C.G., Gieroba, Z., Thompson, C., & Frith, P.A., 2011. Influence of oxygen on ergoreflex and cardiovascular parameters in chronic heart failure. Heart Lung and Circulation, 20(Suppl 20).

Paul, B., Magnoni, A., De Pasquale, C.G., Gieroba, Z., Thompson, C., & Frith, P.A., 2011. Influence of acute oxygen therapy on maximal exercise in chronic heart failure. Heart Lung and Circulation, 20(Suppl 20).

Frith, P.A., Abernethy, A.P., Currow, D.C., & Plummer, J.L., 2007. Predicting response to opioids for relief of dyspnoea. Respirology, 12(Suppl. 1), A50-A50.

Harris, M., Smith, B., Veale, A., Esterman, A.J., Frith, P.A., & Selim, P., 2005. Informed consumers as drivers of evidence based medicine: a trial. XIII International Cochrane Colloquium.

Currow, D.C., Abernethy, A.P., Bui, C., McHugh, A., Fazekas, B.S., Frith, P.A., & Samsa, G., 2003. A randomised double-blind placebo controlled cross-over trial of oral morphine for refractory dyspnoea. 5th Asia Pacific Hospice Conference Program and Abstracts.

Catcheside, P.G., Smith, J.H., Eckert, D.J., Frith, P.A., Schembri, D., & McEvoy, R.D., 2003. Hypoxia and hypercapnic hyperventilation depress inspiratory resisitive load magnitude perception in asthmatics (Abstract). Respirology, 8(Suppl. 2), A29-A29.

Catcheside, P.G., Smith, J.H., Eckert, D.J., Frith, P.A., Schembri, D., & McEvoy, R.D., 2003. Hypoxia and hypercapnic hyperventilation depress inspiratory resisitive load magnitude perception in asthmatics (Abstract). American Journal of Respiratory and Critical Care Medicine, 167.

Eckert, D.J., Smith, J.E., Catcheside, P.G., Frith, P.A., Schembri, D., & McEvoy, R.D., 2003. Hypoxia suppresses symptom perception in asthma. American Journal of Respiratory and Critical Care Medicine, 167.

Frith, P.A., Battersby, M.W., McDonald, P.J., & Mcgowan, C., 2001. Improving processes and clinical care in the SA HealthPlus coordinated care trial. The Australian Coordinated Care Trials; Reflections and Lessons, 69-78.